Transcript
Dr. McGee:
Hi, I'm Selina McGee, the founder of Bespoke Vision in Edmond, Oklahoma.
[On-screen text]
Dr. McGee is a paid consultant of Bausch & Lomb.
Dr. McGee:
I'd like to walk you through how I talk to patients with dry eye disease about MIEBO. When I introduce MIEBO, I tell patients, "I'm going to have you use this drop 4 times a day." And I always like to give some directions.
And so, I will simply say, “Use it at breakfast, lunch, dinner, and bedtime.” And one thing I really like to tell patients is the fact that this drop is really tiny.
It's different from most other drops that they've historically used, because this doesn't have water in it.
[On-screen text]
Drop size is 11 μL. Other drops containing water may have a drop size of 35 μL to 50 μL.
Dr. McGee:
This drop is 100% perfluorohexyloctane, which is the active ingredient in the molecule that helps keep your tears from evaporating. So, when you put this on the front surface of your eye, you may not even feel it.
[On-screen text]
The exact mechanism of action of MIEBO in dry eye disease is not known.
Dr. McGee:
And a lot of patients will actually tell me that if they do feel it, it feels really silky. To administer the medication, I'll tell them, “Draw a bit of air into the bottle by gently squeezing the bottle, turning it upside down and then releasing the pressure.”
[On-screen text]
TIPS FOR PATIENTS
Look at the tip of the MIEBO bottle when you drop it in. Use a mirror to help place MIEBO in your eye. Only use MIEBO as directed.
Dr. McGee:
Now that the bottle is upside down with a bit of air in it, place it above your eye and gently squeeze again to release the drop into your eye. This way you just get one drop at a time and your prescription is going to last you for your full 30 days.
Announcer:
INDICATION
MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
- Instruct patients to instill one drop of MIEBO into each eye four times daily
- The safety and efficacy in pediatric patients below the age of 18 have not been established
- The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information for MIEBO at MIEBO-ECP.COM.
